Small companies, small molecules

Survey of small molecule DD companies. Especially interesting is Targen, who's efforts are described here (Src and PI-3).

Also interesting is how one company (Biotica) seems to exist to develop derivatives of rapamycin, seeking greater efficacy and stability.